Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020;79(1):13-19.
doi: 10.1159/000496294. Epub 2019 Jan 30.

Could Dietary Glutamate Play a Role in Psychiatric Distress?

Affiliations
Review

Could Dietary Glutamate Play a Role in Psychiatric Distress?

A Zarina Kraal et al. Neuropsychobiology. 2020.

Abstract

Glutamate is an amino acid that functions as an excitatory neurotransmitter. It has also been associated with somatic and psychiatric distress and is implicated in the pathophysiology of psychiatric disorders such as schizophrenia. Ingestion of dietary glutamate, such as monosodium glutamate (MSG), has been mechanistically linked with greater distress among patients with chronic pain conditions, though findings have been equivocal. Preliminary research suggests that an MSG-restricted diet confers beneficial effects on somatic symptoms and well-being for some individuals with chronic pain conditions. In addition to associations with somatic distress, glutamate has been associated with the onset and progression of psychiatric symptoms. Thus, the role of dietary glutamate in psychiatric distress represents an underdeveloped and potentially important area for future research aimed at clarifying pathophysiological mechanisms and identifying targets for dietary intervention in psychiatric illnesses.

Keywords: Diet; Fibromyalgia; Glutamate; Monosodium glutamate; Pain; Psychiatric symptoms.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Cairns BE. Influence of pro-algesic foods on chronic pain conditions. Expert Rev Neurother. 2016;16(4):415–423. doi:10.1586/14737175.2016.1157471. - DOI - PubMed
    1. Graybeal C, Kiselycznyk C, Holmes A. Stress-Induced Deficits in Cognition and Emotionality: A Role for Glutamate. In: Springer, Berlin, Heidelberg; 2011:189–207. doi:10.1007/7854_2011_193. - DOI - PMC - PubMed
    1. Coyle JT. The Glutammatergic Dysfunction Hypothesis for Schizophrenia. Harv Rev Psychiatry. 1996;3(5):241–253. - PubMed
    1. Carlson LE, Speca M, Patel KD, Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology. 2004;29(4):448–474. - PubMed
    1. Sanacora G, Treccani G, Popoli M. Towards a glutamate hypothesis of depression.Neuropharmacology. 2012;62(1):63–77. doi:10.1016/j.neuropharm.2011.07.036. - DOI - PMC - PubMed

MeSH terms